Face Prostate Cancer with Prolaris
Prolaris is an in-depth assessment of a patient’s prostate cancer aggressiveness. It is the only test that measures how fast a prostate cancer tumor is growing.
“It Had Affected My Family As Much As It Had Affected Just Me.”
A patient’s prostate cancer journey with genetic and genomic testing
Patient Impact
How Prolaris has shaped patients’ lives
Avoid unnecessary treatments that bring unwanted side effects, costs, and trauma to your family.
-
9 out of 10
patients pay $0 -
average out of pocket cost -
Clinically validated
in all risk groups -
clinical validation studies -
more predictive than PSA and Gleason alone
Step 1
Tissue Sampling
Your prostate tissue sample will be sent to Myriad’s laboratories where it will be tested and analyzed to determine the aggressiveness of your prostate cancer.
Step 2
Testing & Analysis
Your tissue sample is shaved into thin sections and attached to slides which are then dyed and processed. Remaining tissue is sent back to the pathology lab.
Step 3
Discuss Results
Once your sample(s) have been processed, the results are sent directly to your physician. Your result will contain your personalized Prolaris Score™ as well as your 10-year prostate cancer-specific mortality risk.
How Can We Help Direct You?
Depending on your situation, we’d like to ensure we show you the most relevant information possible.
Myriad, the Myriad logo, Prolaris, Prolaris Score and the Prolaris logo are either trademarks or registered trademarks of Myriad Genetics, Inc., in the United States and other jurisdictions.
©2018 Myriad Genetic Laboratories, Inc.